THE CHROMOSOME | Clinical Content Series
Low Testosterone
Back to Case Studies ArchiveCase Study
He was 44 years old and had spent three years being told he was fine. His annual blood tests had returned within normal limits each time. His blood pressure was acceptable. His fasting glucose was normal. His cholesterol was borderline but manageable. By every measure his previous physicians had applied he was a healthy middle aged Pakistani man experiencing the entirely expected consequences of a busy professional life and the natural process of getting older.
He was not fine. He had gained 29 kilograms across five years, predominantly around his abdomen. He had lost the muscle definition he had maintained through his thirties without any reduction in his physical activity. He was exhausted by early afternoon every day regardless of how much he had slept the night before. His concentration had deteriorated to the point where his work was being affected. His libido had disappeared so gradually that he had not noticed it leaving, he had simply arrived one day at the realisation that it had been absent for years. He had not told his physician any of this because in Pakistan these are not things a man discusses with his doctor. They are things a man carries in silence and attributes to age and pressure and the weight of responsibility.
They are also, in a significant proportion of Pakistani men, the precise clinical signature of low testosterone, a condition that is simultaneously one of the most prevalent and one of the most consistently undiagnosed hormonal disorders in Pakistani male medicine.
When I took his full history and insisted on a complete hormonal assessment, not merely the standard metabolic panel that had been reassuring his physicians for three years, his total testosterone was 187 nanograms per decilitre. The lower limit of the normal range is 300. His free testosterone, the biologically active fraction, was even more dramatically suppressed because his SHBG was elevated, binding the limited testosterone available and reducing what his tissues could actually use. His LH was inappropriately low for his degree of testosterone deficiency, confirming a secondary hypogonadism in which the pituitary was failing to drive adequate testicular stimulation. His oestrogen was elevated, converted from the testosterone his visceral fat was aromatising before it could reach its target tissues.
He had not been ageing normally. He had been hormonally depleted for years while a standard blood panel told his physicians everything was fine, because testosterone is not part of a standard blood panel in Pakistani clinical practice unless the physician thinks to order it. And in Pakistani medicine, testosterone is thought about for sexual dysfunction. It is almost never thought about for weight gain, fatigue, cognitive decline, or metabolic deterioration, which are, in the majority of Pakistani men I see with this condition, its primary and most debilitating manifestations.
The FTO gene's influence on hypothalamic pituitary gonadal axis regulation in Pakistani men creates a predisposition to secondary testosterone deficiency that is activated and amplified by visceral fat accumulation, insulin resistance, chronic stress, and sleep disruption, all of which are prevalent in Pakistani urban professional life and all of which suppress testosterone through independent biological pathways that compound each other progressively. By the time a Pakistani man presents with the clinical picture I was looking at across my desk, the testosterone suppression has typically been operating for years and the metabolic consequences have been accumulating silently throughout.
The closed loop between low testosterone and visceral obesity is one of the most clinically important relationships I address in Pakistani male patients. Low testosterone promotes visceral fat accumulation, visceral fat aromatises testosterone to oestrogen, elevated oestrogen suppresses the hypothalamic LH signal, reduced LH drives testosterone lower, lower testosterone promotes more visceral fat. This loop tightens with every passing year of inadequate treatment and cannot be broken by diet, exercise, or any intervention that does not address the testosterone deficiency at its hormonal origin.
We broke the loop. We restored his testosterone through the clinically appropriate pathway. We simultaneously treated his insulin resistance, which had been independently suppressing testosterone through its effects on SHBG and hypothalamic function. We reduced his visceral fat, removing the aromatase driven oestrogen excess that had been suppressing his LH signal. We recalibrated his cortisol, which had been competing with testosterone for pregnenolone precursor and suppressing gonadotropin releasing hormone simultaneously. We addressed his sleep architecture, because the majority of daily testosterone production occurs during deep sleep and his shallow disrupted sleep had been reducing his testosterone output nightly for years.
Fifteen months later his total testosterone was 524 nanograms per decilitre, within the optimal range. He had lost 26 kilograms. His muscle had returned visibly. His afternoon energy collapse had resolved. His concentration had recovered to the point where he described his cognitive function as sharper than it had been in a decade. His libido had returned. He had told his wife, with some embarrassment, that he felt thirty again.
He had not been ageing. He had been depleted. And depletion, unlike ageing, responds to treatment.
FAQs
Low testosterone in Pakistani men presents predominantly as progressive abdominal weight gain, afternoon energy collapse, loss of muscle mass despite maintained physical activity, deteriorating concentration and cognitive sharpness, low mood without clear psychological origin, and gradually disappearing libido that occurs so slowly it is attributed to age rather than identified as a symptom. Pakistani men do not present to physicians complaining of low testosterone, they present complaining of fatigue, weight gain, and stress. Pakistani physicians do not respond by measuring testosterone, they reassure, advise lifestyle modification, or prescribe antidepressants. The hormone driving the entire clinical picture is never measured because the symptoms it produces are never connected to it in Pakistani clinical thinking.
Testosterone exerts a direct inhibitory effect on visceral adipocyte differentiation and fat storage, it suppresses the development of new fat cells in the visceral compartment and promotes the oxidation of existing fat for energy. When testosterone falls, this inhibitory effect is removed and visceral fat accumulates rapidly and preferentially in the deep abdominal compartment. Simultaneously, the muscle mass loss driven by testosterone deficiency reduces resting metabolic rate, further promoting caloric surplus and fat deposition. And the visceral fat that accumulates then aromatises residual testosterone to oestrogen, elevating oestrogen, suppressing the hypothalamic LH signal, and driving testosterone lower in a self reinforcing cycle that tightens progressively without intervention.
The FTO gene at Chromosome 16q12.2 influences hypothalamic gonadotropin releasing hormone pulsatility, the signal that initiates the cascade driving pituitary LH production and ultimately testicular testosterone synthesis. In Pakistani men, the FTO associated metabolic profile creates a predisposition to hypothalamic suppression of this cascade under the metabolic stress of visceral obesity, insulin resistance, and chronic cortisol elevation, conditions that are both more prevalent and more metabolically damaging in Pakistani men with this genetic background. Dr. Zaar consistently identifies secondary hypogonadism, where the testes are capable of producing testosterone but are not receiving adequate pituitary stimulation, as the predominant pattern in Pakistani men with low testosterone, reflecting the hypothalamic origin of the deficiency.
Approximately seventy percent of daily testosterone production occurs during sleep, specifically during the slow wave and REM sleep stages that are most vulnerable to disruption. Pakistani men with the disrupted sleep patterns characteristic of urban professional life, late nights, early mornings, fragmented sleep from stress and screen exposure, are suppressing their testosterone production nightly by reducing the deep sleep stages during which it occurs. The cumulative testosterone deficit from years of poor sleep is substantial and clinically significant, yet sleep is almost never evaluated as a driver of testosterone deficiency in Pakistani clinical practice. Dr. Zaar assesses sleep architecture as a core component of every male testosterone evaluation, because restoring sleep restores a significant proportion of testosterone production without any pharmacological intervention.
In the majority of Pakistani men with secondary hypogonadism, where the testicular tissue remains capable of production but is not receiving adequate hypothalamic and pituitary stimulation, meaningful testosterone recovery is achievable through comprehensive metabolic intervention without direct testosterone replacement. Visceral fat reduction removes the aromatase driven oestrogen excess suppressing the LH signal. Insulin resistance treatment restores SHBG to appropriate levels, increasing free testosterone bioavailability. Cortisol recalibration removes the pregnenolone competition that depletes testosterone precursor. Sleep restoration reinstates the deep sleep dependent testosterone production that has been suppressed nightly. Where these interventions restore testosterone to optimal levels, replacement therapy is unnecessary. Where deficiency persists despite comprehensive metabolic restoration, testosterone replacement is incorporated into THE CHROMOSOME protocol as a precisely calibrated component of a broader hormonal strategy.
Testosterone and insulin sensitivity exist in a bidirectional relationship of mutual support, testosterone promotes insulin sensitivity in muscle tissue by enhancing glucose uptake and oxidation, while insulin sensitivity supports the hypothalamic pituitary function required for testosterone production. When testosterone falls, muscle insulin sensitivity deteriorates, worsening insulin resistance and driving the compensatory hyperinsulinaemia that further suppresses testosterone through its effects on SHBG and hypothalamic function. This bidirectional suppressive cycle between low testosterone and insulin resistance is one of the most metabolically destructive relationships in Pakistani male obesity, and it cannot be broken by addressing either condition in isolation. THE CHROMOSOME protocol treats both simultaneously because the metabolic cycle connecting them operates in both directions and must be interrupted at every point simultaneously.
Testosterone plays a critical protective role in cardiovascular health, maintaining endothelial function, reducing inflammatory cytokine production, supporting cardiac muscle contractility, promoting favourable lipid profiles through HDL elevation and triglyceride reduction, and inhibiting the atherosclerotic processes that drive coronary artery disease. Its deficiency removes these protective effects simultaneously, creating a cardiovascular risk environment characterised by endothelial dysfunction, elevated inflammatory markers, unfavourable lipid profiles, increased visceral fat, and impaired cardiac function. Pakistani men with low testosterone develop cardiovascular disease earlier, more severely, and at lower degrees of traditional risk factor burden than testosterone replete men, yet testosterone is almost never evaluated as a cardiovascular risk factor in Pakistani cardiology practice. Dr. Zaar treats testosterone deficiency as a cardiovascular risk intervention as much as a metabolic and hormonal one.
Testosterone is a neurosteroid, it exerts direct effects on brain function, mood regulation, cognitive performance, and emotional resilience. Its deficiency produces a psychological profile characterised by low mood, reduced motivation, impaired concentration, emotional volatility, loss of competitive drive, and a pervasive sense of diminished vitality that Pakistani men consistently describe as no longer feeling like themselves. This psychological profile is almost universally attributed to depression, work stress, or marital difficulty in Pakistani clinical practice, and antidepressants are prescribed for what is fundamentally a hormonal deficiency. Serotonin reuptake inhibitors do not restore testosterone. They mask its deficiency while the underlying hormonal and metabolic deterioration continues. THE CHROMOSOME protocol addresses the testosterone deficiency directly, and the psychological restoration that follows hormonal restoration is, in Dr. Zaar's clinical experience, among the most profound and most rapidly apparent benefits of comprehensive treatment.